FDA Approves Updated COVID Vaccines
Digest more
Monoclonal antibody treatments are saving lives from COVID-19 and helps keep patients out of Triangle hospitals.
14h
Invivyd: Superior COVID Prophylaxis; Eventual Winner Regardless Of Trump Admin Anti-Vaccine Actions
As it stands, there will be no updated COVID vaccine approved for the upcoming fall/winter 2025 vaccination season, and neither Moderna nor Pfizer/BioNTech has guided that they will run trials to pursue (re)approval in healthy patients.
With omicron's explosive spread threatening to outpace current COVID-19 treatments, the race is on to find new ones that will stand up to the new variant.
As North Carolina hospitals report record COVID patients, Gov. Cooper says he will take action to expand monoclonal antibody treatment access.
The discovery of a possible universal vaccine comes amid summer COVID-19 surge, as researchers warn current vaccines fall short against circulating variants.
These tests help identify patients who have antibodies in their blood and would like to donate their plasma as part of an experimental COVID-19 treatment for those who are critically ill or need ...
While the FDA granted emergency use authorization to Regeneron and Eli Lilly's antibody treatments in November 2020, many healthcare organizations have been slow to adopt these treatments due to a ...
Kirk claimed that in Minnesota, Walz rationed access to monoclonal antibody treatments for COVID-19 based on skin color, and that white people died because they were denied access.
Bay Area researchers created a group of AI “scientists” that proposed a potential COVID treatment. They say the approach could accelerate scientific research.
New research led by Caltech has characterized a multitude of antibodies to the virus that causes COVID-19 and identified those that are most effective at neutralizing the virus. Antibodies are ...
Our ruling Kirk claimed that in Minnesota, Walz rationed access to monoclonal antibody treatments for COVID-19 based on skin color, and that white people died because they were denied access.
Invivyd's Covid-19 PrEP faces waning demand, but its pipeline advancements in RSV and HBV could drive future growth. See why I'm downgrading IVVD stock to Hold.
Feedback